Market Share of Global Patient Derived Xenograft Models Industry
The patient-derived xenograft market is consolidated in nature due to the presence of a few key companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known, including Champions Oncology, Inc., Crown Bioscience, Inc., Charles River Laboratories, Inc., EPO Berlin-Buch GmbH, Hera BioLabs, Oncodesign, Pharmatest Services Ltd, Urolead and Xentech among others.
Patient Derived Xenograft Models Market Leaders
Champions Oncology, Inc.
Crown Bioscience, Inc.
Charles River Laboratories, Inc.
EPO Berlin-Buch GmbH
Oncodesign
*Disclaimer: Major Players sorted in no particular order
